FDA product code IZQ: Injector, Contrast Medium, Automatic
IZQ is the FDA product code for injector, contrast medium, automatic. It is a Class II device, regulated under 21 CFR 870.1650 and reviewed by the General Hospital panel. FDA has cleared 23 510(k) submissions under IZQ, 7 in the last five years, from 14 different applicants. The average 510(k) review took 139 days (median 147); 90 days on average over the last three years. FDA has posted 3 recalls for IZQ devices.
Classification
| Field | Value |
|---|---|
| Device name | Injector, Contrast Medium, Automatic |
| Device class | Class II |
| Regulation | 21 CFR 870.1650 |
| Review panel | HO — General Hospital |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for IZQ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 182 |
| 2020 | 1 | 268 |
| 2021 | 1 | 163 |
| 2024 | 3 | 113 |
| 2025 | 3 | 115 |
| 2026 | 1 | 41 |
Compare with all 510(k) review times · Search every IZQ clearance
Top IZQ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Ulrich GmbH & Co. KG | 7 | 2025-11-18 |
| Imaxeon Pty, Ltd. | 2 | 2025-09-24 |
| E-Z-Em, Inc. | 2 | 2007-04-13 |
| Bd Becton Dickinson Vacutainer Systems Preanalytic | 2 | 1976-10-08 |
| ACIST Medical Systems, Inc. | 1 | 2026-08-03 |
9 more applicants have IZQ clearances. See the full list in Caduvo.
Most recent IZQ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K262115 | ACIST Medical Systems, Inc. | VueJect® Ultrasound Enhancing Agent Delivery System | 2026-08-03 | 41 |
| K252281 | Ulrich GmbH & Co. KG | ulricheasyINJECT Max 2M (XD 10140); ulricheasyINJECT Max 3 (XD 10150); ulricheasyINJECT Max 3 (XD 10180) | 2025-11-18 | 119 |
| K251295 | Ulrich GmbH & Co. KG | ulrichINJECT CT Motion (XD 8000) | 2025-11-07 | 196 |
| K252689 | Imaxeon Pty, Ltd. | MEDRAD Centargo CT Injection System; MEDRAD Centargo Day Set; MEDRAD Centargo Patient Line; MEDRAD Centargo Replacement Spike; MEDRAD ISI2 Module (ISI2) | 2025-09-24 | 29 |
| K241849 | Imaxeon Pty, Ltd. | MEDRAD Centargo CT Injection System; MEDRAD Centargo Day Set; MEDRAD Centargo Patient Line; MEDRAD Centargo Replacement Spike; MEDRAD ISI2 Module (ISI2) | 2024-11-05 | 131 |
Recalls for IZQ devices
3 product recalls in 3 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2011-10-11.
Frequently asked questions
What is FDA product code IZQ?
IZQ is the FDA product code for injector, contrast medium, automatic. It is a Class II device, regulated under 21 CFR 870.1650 and reviewed by the General Hospital panel.
What device class is IZQ?
Class II, regulation 21 CFR 870.1650. Typical premarket route: 510(k).
How long does a 510(k) take for product code IZQ?
Across 23 cleared submissions the average was 139 days from receipt to decision (median 147).
Which companies have the most IZQ clearances?
Ulrich GmbH & Co. KG (7); Imaxeon Pty, Ltd. (2); E-Z-Em, Inc. (2); Bd Becton Dickinson Vacutainer Systems Preanalytic (2); ACIST Medical Systems, Inc. (1).
Have IZQ devices been recalled?
Yes: 3 product recalls across 3 recall events; the most recent began 2011-10-11.
Next steps
- Run an FDA pathway report with predicate devices for product code IZQ
- Run a recall and safety report across every IZQ manufacturer
- Watch product code IZQ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All General Hospital product codes · FDA product code lookup · 510(k) database search · 510(k) review times